The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
This report contains market size and forecasts of Self Injection Device in global, including the following market information:
Global Self Injection Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Self Injection Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Self Injection Device companies in 2021 (%)
The global Self Injection Device market was valued at 9034.3 million in 2021 and is projected to reach US$ 12210 million by 2028, at a CAGR of 4.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Reusable Self Injection Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Self Injection Device include Novo Nordisk, Mylan, Pfizer, Sanofi, BD, Eli Lilly, Gerresheimer, Dongbao and Ypsomed, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Self Injection Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Self Injection Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Self Injection Device Market Segment Percentages, by Type, 2021 (%)
Reusable Self Injection Device
Disposable Self Injection Device
Global Self Injection Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Self Injection Device Market Segment Percentages, by Application, 2021 (%)
Insulin Injection
Epinephrine Injection
Others
Global Self Injection Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Self Injection Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Self Injection Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Self Injection Device revenues share in global market, 2021 (%)
Key companies Self Injection Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Self Injection Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Mylan
Pfizer
Sanofi
BD
Eli Lilly
Gerresheimer
Dongbao
Ypsomed
Owen Mumford
Antares Pharma
Haselmeier

LEAVE A REPLY

Please enter your comment!
Please enter your name here